IMARC Group’s latest research report, titled “High-throughput Screening Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2022-2027,” offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends, and competitive landscape to understand the current and future market scenarios.
What is the projected market value of the global High-Throughput Screening Market?
The global high-throughput screening market reached a value of US$ 21.35 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 35.53 Billion by 2027, exhibiting a CAGR of 8.60% during 2022-2027.
High-throughput screening (HTS) is a drug discovery procedure that allows mechanical testing of various chemical and natural compounds for a biological target. It relies on plate readers, liquid handling devices, robotics, dedicated software, etc., for data processing and instrumentation control. HTS enables high-speed automation, sample minimization, single-molecule, and low background signal detection. It assists scientists in generating and utilizing large datasets for answering complex biological questions. As a result, HTS finds widespread applications in target validation, pharmaceuticals, biotech and academic institutes, and identifying genes that modulate a particular biological pathway.
Request a PDF Sample Copy for more detailed market insights: https://www.imarcgroup.com/high-throughput-screening-market/requestsample
Important Attribute and highlights of the Report:
- Detailed analysis of the global market share
- Market Segmentation by technology, products and services, applications, end user and region.
- Historical, current, and projected size of the market in terms of volume and value
- Latest industry trends and developments
- Competitive Landscape for high-throughput screening market
- Strategies of major players and product offerings
The escalating requirement for this procedure to minimize the time required for manufacturing a drug and the development of new medicines for treating several life-threatening diseases are primarily driving the high-throughput screening market. Besides this, the launch of favorable policies by the government bodies to invest in the latest technologies, such as clustered regularly interspaced short palindromic repeats (CRISPR), microplate-free approach, RNA interference (RNAi), machine learning (ML), artificial intelligence (AI), etc., is further augmenting the market growth.
Apart from this, the growing popularity of the time-resolved Forster resonance energy transfer (TR-FRET) version of the transcreener assay for various enzymes is also catalyzing the global market. Moreover, the introduction of label-free procedures to provide simple methods for studying complex biological pathways and reduce the risk of medicine failure caused by toxicity is expected to bolster the high-throughput screening market in the coming years.
Key Players Included in Global Research Report:
- Agilent Technologies Inc.
- Aurora Biomed Inc.
- Axxam S.p.A
- Beckman Coulter Inc. (Danaher Corporation)
- Bio-RAD Laboratories Inc.
- Charles River Laboratories International Inc.
- Corning Incorporated
- Luminex Corporation (DiaSorin)
- Perkinelmer Inc.
- Sygnature Discovery
- Tecan Group Ltd.
- Thermo Fisher Scientific.
Do you know more information, Contact to our analyst at– https://www.imarcgroup.com/high-throughput-screening-market
Note: As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviors of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic
Breakup by Technology:
- Ultra-High-Throughput Screening
- Cell-Based Assays
- Label-Free Technology
Breakup by Products and Services:
- Reagents and Kits
Breakup by Applications:
- Target Identification and Validation
- Primary and Secondary Screening
- Toxicology Assessment
Breakup by End User:
- Pharmaceutical and Biotechnology Firms
- Academic and Government Institutes
- Contract Research Organizations
Breakup by Region:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
TOC for the High-throughput Screening Market Research Report:
- Scope and Methodology
- Executive Summary
- Global High-throughput Screening Market
- SWOT Analysis
- Value Chain Analysis
- Price Analysis
- Competitive Landscape
Who we are:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: [email protected]
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800